The putative mechanistic basis for the modulatory role of endothelin-1 in the altered vascular tone induced by Trypanosoma cruzi

Endothelium: Journal of Endothelial Cell Research

Volumn 6, Issue 3, 1999, Pages 217-230

  Tanowitz, Herbert B ^a   Wittner, Murray ^a   Morris, Stephen A ^a,b   Zhao, Weixin ^a   Weiss, Louis M ^a   Hatcher, Victor B ^a   Braunstein, Vicki L ^a   Huang, Huan ^a   Douglas, Stephen A ^c   Valcic, Mira ^a   Spektor, Mariya ^a   Christ, George J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Columbia University ^*  (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Chagas' disease; Endothelial cells; Endothelin; Phosphoramidon; Trypanosoma cruzi; Vascular smooth muscle cells; Verapamil

Indexed keywords

5 DIMETHYLAMINO N (3,4 DIMETHYL 5 ISOXAZOLYL) 1 NAPHTHALENESULFONAMIDE; CALCIUM ION; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; FURA 2; PHOSPHORAMIDON; VERAPAMIL;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; BIOASSAY; BLOOD VESSEL TONE; CALCIUM TRANSPORT; CELL CULTURE; CHAGAS DISEASE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE FIBER; SUPERNATANT; TRYPANOSOMA CRUZI; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALIA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0032921134     PISSN: 10623329     EISSN: None     Source Type: Journal    
DOI: 10.3109/10623329909053412     Document Type: Article

References (64)

1. Barnes K., Shimada K., Takahashi M., Tanzawa K. and Turner A.J. (1996) Metalloprotease inhibitors induce an up-regulation of endothelin-converting enzyme levels and its redistribution from the plasma membrane to an intracellular compartment. Journal of Cell Science, 109, 919-928.
2. Bergsma D.J. Elshourbagy N. and Kumar C. (1995) Molecular biology of endothelin receptors. In Endothelin Receptors from the Gene to the Human (ed., R.R. Ruffolo) CRC Press, Boca Raton, pp.37-57.
3. Bonadonna G., Lechi C., Corradini P., Sinigaglia D., De Togni P., and Miroslawa G. (1986) Verapamil inhibits platelet aggregation by a calcium-independent mechanism. Thrombosis and Haemostasis, 56, 308-310.
4. Brown C.D., Barnes K. and Turner A.J. (1998) Anti-peptide antibodies specific to rat endothelin-converting enzyme-1 isoforms reveal isoform localisation and expression. FEBS Letters, 424, 183-187
5. Christ G.J. (1990) Estimation of agonist dissociation constants in isolated vasculature: Equivalence of estimates obtained with the method of partial irreversible receptor inactivation and a novel application of the operational model of pharmacological agonism. Life Sciences, 47, 1867-1874.
6. Christ G.J. (1992a) Age- and pathology-dependent alterations in the efficacy of phenylephrine- and 5-hydroxytryptamine-induced contractions in isolated rat aorta. Drug Development Research, 25, 303-314.
7. 1-adrenergic agonist efficacy in isolated rat aorta. Journal of Pharmacology and Experimental Therapeutics, 266, 1054-1065.
8. 2 receptors in isolated rat aorta. Journal of Pharmacology ami Experimental Therapeutics, 256, 553-561.
9. 2+ in cultured human corporal smooth muscle cells. American Journal of Physiology, 263, C373-C383.
10. Christ G.J., Valcic M. and Gondré C.M. (1994) Augmentation in the kinetic characteristics of phenylephrine- and 5-hyroxytryptamine-induced contractions in the isolated rat aorta following 8 weeks of STZ-diabetes. Life Sciences, 55, 807-814.
11. Christ, G.J., Brink, P.R., Melman, and Spray, D.C. (1993b) The role of gap junctions and ion channels in the modulation of chemical and electrical signals in human corpus cavernosum smooth muscle. Int. J. Impotence Res., 5, 77-96.
12. Douglas S.A. (1997) Clinical development of endothelin antagonists. Trends in Pharmacological Sciences, 18, 408-412.
13. Douglas S.A. and Ohlstein S.A. (1996) Signal transduction mechanisms mediating the vascular actions of endothelin. Journal of Vascular Research, 334, 152-164.
14. Emoto N. and Yanagisawa M. (1995) Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. Journal of Biological Chemistry, 270, 15262-15268.
15. Factor, S.M., Cho S., Wittner M., and Tanowitz H. (1985) Abnormalities of the coronary microcirculation in acute murine Chagas' disease. American Journal of Tropical Medicine and Hygiene, 34, 246-253.
16. 2+ in cultured arterial smooth muscle cells using fura-2 and digital imacina microscopy. Cell Calcium, 11, 221-231.
17. Gondré, C.M. and Christ, G.J. (1998) Endothelin-1 (ET-1)-induced alterations in phenylepherine-induced contractile responses are largely additive in physiologically diverse rabbit vasculature. Journal of Pharmacology and Experimental Therapeutics, 286, 635-642.
18. Gordon, P.B., Sussman I. And Hatcher V.B. (1983) Longterm cultures of human endothelial cells. In Vitro, 19, 661-671.
19. Guarda E., Katawa L.V., Myers P.R., Tyagi S.C. and Weber K.T. (1993) Effects of endothelins on collagen turnover in cardiac fibroblasts. Cardiovascular Research, 27, 2130-2134.
20. Ishikawa T., Yanagisawa M., Kimura S., Goto K. and Masaki T. (1988) Positive inotropic action of a novel vasoconstrictor peptide endothelin on guinea pig atria. American Journal of Physiology, 255, 11970-973.
21. Kelly R., Hursey T.L., Schaer G.L., Piotrowski M.S., Dee S.V., Parrillo J.E., Hollenberg S.M. (1996) Cardiac endothelin release and infarct size, myocardial blood flow, and ventricular function in canine infarction and reperfusion. Journal of Investigative Medicine, 44, 575-582.
22. Krum H., Gu A., Wilshire-Clement M., Sackner-Bernstein J., Goldsmith R., Medina N., Yushak L., Miller, and Packer M. (1996) Changes in plasma endothelin-1 levels reflect clinical response to β-blockade in chronic heart failure. American Heart Journal, 131, 337-341.
23. Luscher T.F., Seo B.G., Buhler E. (1993) Potential role of endothelin in hypertension. Controversy on endothelin in hypertension. Hypertension, 21, 752-757.
24. 2+imaging in single living cells: Theoretical and practical issues. Cell Calcium, 11, 157-179.
25. Morris S.A., Bilezikian J.P., Weiss L., Tanowitz H.B. and Wittner M. (1989a) Trypanosoma cruzi: infection of cultured human endothelial cells alters inositol phosphate synthesis. Experimental Parasitology, 69, 330-339.
26. Morris S.A., Tanowitz H.B., Factor S.M., Bilezikian J.P. and Wittner M. (1988) Alterations in intracellular calcium following infection of human endothelial cells with Trypanosoma cruzi. Molecular and Biochemical Parasitology, 29, 213-221.
27. Morris S.A., Tanowitz H.B., Makman M., Hatcher V., Bilezikian J.P. and Wittner M. (1992) Trypanosoma cruzi: Infection of human umbilical endothelial cells alter cAMP metabolism. Experimental Parasitology, 74, 69-76.
28. Morris S.A., Weiss L.M., Factor S.M., Bilezikian J.P., Tanowitz H.B. and Wittner M. (1989b) Verapamil ameliorates clinical, pathological and biochemical manifestations of experimental chagasic cardiomyopathy in mice. Journal of the American College of Cardiology, 14, 782-789.
29. Mulder P., Richard V., Derumeaux G., Hoggie M., Henry J.P., Lallemand F., Compagnon P., Mace Comoy E., Letac B. and Thuillez, C. (1997) Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling. Circulation, 96, 1976-1982.
30. Nakayama K., Ishigai Y., Uchida H., Tanaka Y. (1991) Potentiation by endothelin of 5-hydroxytryptamine-induced contraction in the coronary artery of the pig British Journal of Pharmacology, 104, 978-986.
31. Ohlstein E.H., Beck G.R., Douglas S.A., Nambi P., Lago M.A., Gleason J.G., Ruffolo R.R., Fuerstein G. and Elliot J.D. (1994) Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670. Journal of Pharmacology and Experimental Therapeutics. 271, 762-768.
32. Ohlstein E.L. and Douglas S.A. (1997a) Endothelin and the control of cardiovascular remodeling. Pharmacological Reviews and Communications, 9, 71-79.
33. Ohlstein E.H. and Douglas S.A. (1997b) Endothelin and the pathogenesis of restenosis In Coronary Restenosis From Genetics to Therapeutics (ed. G. Z. Feuerstein), Marcel Dekker, Inc New York, pp. 129-142.
34. Omland T., Lie R.T., Aakvaag A., Aarsland T. and Dickstein K. (1996) Plasma endothelin determination as a prognostic of 1 year mortality after acute myocardial infarction. Circulation, 89, 1573-1579.
35. Parnot C., Le Moullec J.M., Cousin M.A., Guedin D., Corvol P. and Pinet F. (1997) A live cell assay for studying extracellular and intracellular endothelin-converting enzyme activity. Hypertension, 30, 837-844.
36. Petersson J., Hanson G.C., Lindberg B.F. and Hogestatt E.D. (1996) Contractile effect of big endothelin-1 and its conversion to endothelin-1 in rabbit cerebral arteries. Naunyn-Schmeideberg's Archives of Pharmacology, 354, 656-661.
37. Pi Y. Sreekumar R., Huang X. and Walker J.W. (1997) Positive inotrophy mediated by diacylglycerol in rat ventricular myocyte. Circulation Research, 81, 493-497.
38. Rajagopalan S., Laursen J.B., Borthayre A., Kurz S., Keiser J., Haleen S., Giaid A. and Harrison D.G. (1997) Role for endothelin-1 in angiotensin 11-mediated hypertension. Hypertension, 30, 29-34.
39. Raschack M., Unger L., Reichers H. and Klinge D. (1995) Receptor selectivity of endothelin antagonists and prevention of vasoconstriction and endothelin-induced sudden death. Journal of Cardiovascular Pharmacology, 26, Supplement 3, S397-S399.
40. Rodeheffer R.J., Lerman A., Heublein D.M. and Burnett Jr., J.C. (1992) Increased plasma concentrations of endothelin in congestive heart failure in humans. Mayo Clinic Proceedings, 67, 719-724.
41. Rowin K.R., Tanowitz H.B., Wittner M., Nguyen H.T. and Nadal-Ginard B. 1983. Inhibition of muscle differentiation by Trypanosoma cruzi. Proceedings of the National Academy of Science USA, 83, 6390-6394.
42. Saleh D., Furukawa K., Tsao M.S., Maghazachi A., Corrin B., Yanagisawa M., Barnes P.J. and Giaid A. (1997) Elevated expression of endothelin-1 and endothelin converting enzyme-1 in idiopathic pulmonary fibrosis: possible involvement of proinflamniatory cytokines. American Journal of Cell and Molecular Biology, 16,187-193.
43. Sakai S., Miyauchi T., Sakurai T., Yamaguchi I., Kobayashi M., Goto K. and Sugishita Y. (1996) Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist. Increased expression of endothelin-1 messenger ribonucleic acid and endothelin-1 -like immunoreactivity in the lung in congestive heart failure in rats. Journal of the American College of Cardiology, 28, 1580-1588.
44. Satoshi S., Miyauchi T., Kobayashi, M., Yamaguchi I., Goto, K. and Sugishita Y. (1996). Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature, 384, 353-355.
45. Schomisch Moravec C., Reynolds E.E., Stewart R.W. and Bond M. (1989) Endothelin is a positive inotropic agent in human and rat heart in vitro. Biochemical and Biophysical Research Communications 159, 14-18.
46. Schweizer A., Valdenaire O., Nelbabock P, Deuschle U. (1997) Human endothelin-converting enzyme (ECE-1): three isoforms with distinct subcellular localizations. Biochemical Journal, 328, 871-877.
47. B receptors mediate contraction to endothelin-1 in human blood vessels. Circulation, 89, 1203-1216.
48. Shah A.M., Lewis M.J. and Henderson A.H. (1989) Inotropic effects of endothelin in ferret ventricular myocardium. European Journal of Pharmacology, 163, 365-370.
49. Sharma A.C., Motew S.J., Farias S., Alden K.J., Bosmann H.B., Law W.R. and Ferguson J.L. (1997) Sepsis alters myocardial and plasma concentrations of endothelin and nitric oxide in rats. Journal of Molecular and Cellular Cardiology, 29, 1469-1477.
50. Staerman, F., Melman, A., Spektor, M. and Christ, G.J. (1997) On the putative mechanistic basis for intraoperative propofol-induced penile erections. Int. J. Impotence, Res. 9, 1-9.
51. Tanowitz H.B., Burns E.R., Sinha A.K., Kahn N.N., Morris S.A., Factor S.M., Hatcher V.B., Bilezikian J.P. and Wittner M. (1990) Enhanced platelet adherence and aggregation in Chagas' disease: a potential pathogenic mechanism for cardiomyopathy. American Journal of Tropical Medicine and Hygiene, 43, 274-281.
52. Tanowitz H.B, Gumprecht J.P., Spurr D., Calderon T.M., Ventura M.C., Raventos-Suarez C, Factor S.M., Hatcher V., Wittner M. and Berman J.W.(1992a) Cytokine gene expression of endothelial cells infected with Trypanosoma cruzi. Journal of Infectious Diseases, 166, 598-603.
53. Tanowitz H.B., Kaul D.K., Chen B., Morris S.A., Factor S.A., Factor S.M., Weiss L.M. and Wittner M. (1996a) Compromised microcirculation in acute murine Trypanosoma cruziinfection. Journal of Parasitology, 82, 124-130.
54. Tanowitz H.B., Kirchhoff L.V., Simon D., Morris S.A., Weiss L.M., and Wittner M. (1992b) Chagas' Disease. Clinical Microbiological Reviews, 5, 400-419.
55. Tanowitz H.B., Wittner M., Chen B., Huang H., Weiss L.M., Christ G.J., Braunstein V., Bilezikian J.P. and Morris S.M. (1996b) Effects of verapamil on acute murine Chagas' disease. Journal of Parasitology, 82, 814-819.
56. Tarleton R.L., Zhang L., and Downs M.O. (1997) "Autoimmune rejection" of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue. Proceedings of the National Academy of Science USA, 94, 3932-3937.
57. Turner A.J. and Murphy L.J. (1996) Molecular pharmacology of endothelin converting enzymes. Biochemical Pharmacology, 51, 91-102.
58. A receptor antagonist. Journal of Pharmacology and Experimental Therapeutics, 212, 1 124-1 134.
59. Willette R.N., Feuerstein G.Z. and Barone F.C. (1995) Endothelin in the central nervous system. In Endothelin receptors. from the gene to the human (ed. R. R. Ruffolo Jr.), CRC Press Boca Raton, pp. 187-213.
60. Winkles J.A., Alberts G.F. Brogi E. and Libby P (1993) Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries. Biochemical and Biophysical Research Communications, 191, 1081-1088.
61. Wittner M., Christ G.J., Huang H., Weiss L.M., Hatcher V.B., Morris S.A., Orr G.A., Berman J.W., Zeballos G.A., Douglas S.A. and Tanowitz H.B. (1995) Trypanosoma cruzi induces endothelin release from endothelial cells. Journal of Infectious Diseases, 171, 493-497.
62. Yanagisawa M., Kurihara H., Kimura S., Kobayashi M., Mitusui Y., Yazaki Y., Goto K. and Masaki T. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 332, 411-415.
63. 2 increases the vasoconstrictor effect of endothelin-1 in post-ischemic reperfused rat hearts. Circulation, 94, 742-747.
64. Zhao W. and Christ G.J. (1995) Endothelin-1 as a putative modulator of erectile dysfunction: II. Calcium mobilization in cultured human corporal smooth muscle cells. Journal of Urology, 154, 1571-1579.